Training programs for research ethics in Zimbabwe
Official title: US-Zimbabwe Research Ethics Training Program (US-Zim RETP)
Funded at George Washington University · NIH-11051793 · Data updated 2026-11-12
This study is working to improve how research ethics is taught at the University of Zimbabwe, aiming to create a Master's program that helps future health researchers understand and follow important ethical standards, so they can conduct research that is safe and respectful for everyone involved.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | April 1, 2024 |
| Project end | December 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $245,529 |
| NIH project number | 5R25TW012713-02 |
| Project ID | NIH-11051793 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include health professionals and researchers in Zimbabwe who are involved in or interested in ethical research practices.
✕Less likely to help
Patients who are not engaged in health research or do not reside in Zimbabwe may not receive direct benefits from this program.
What this research studies
This program aims to enhance research ethics education and training at the University of Zimbabwe's Faculty of Medicine and Health Sciences. It focuses on developing a Master's degree in Research Ethics and improving the teaching capabilities of faculty members. By collaborating with experts, the program seeks to address the growing need for ethical standards in health research, ensuring that research conducted in Zimbabwe meets international ethical guidelines. This initiative will also promote research on critical ethical issues relevant to the country's health challenges.
Why it matters
Potential benefit: If successful, this research could lead to improved ethical standards in health research, ultimately benefiting patient care and safety in Zimbabwe.
How similar studies have gone: Similar initiatives in other regions have successfully enhanced research ethics training and have shown positive impacts on research quality and patient safety.
Where this research is happening
-
George Washington University
Washington, United States Active
Researchers
- Principal investigator: Hyder, Adnan a — George Washington University
- Study coordinator: Hyder, Adnan a
Related research
Other NIH-funded projects on the same topics.
-
HLA-F and KIR3DS1: unlocking NK cell help to control HIV
A short, patient-friendly look at how a specific immune interaction might help the body control HIV and reduce long-term health problems.
-
Emerging therapies for rare maternal mitochondrial diseases with shared causes
A basket clinical trial will test new drug candidates for two ultra-rare mitochondrial diseases (MELAS and LHON-Plus) that share the same underlying energy-making problem in people who could be affected.
-
Anti-cancer vaccine for liver fluke infection and bile duct cancer
A vaccine approach aims to stop liver fluke interactions with the human bile ducts to prevent bile duct cancer in regions where the parasite is common.
-
Anti-cancer vaccine targeting the host-parasite interface during liver fluke infection
A vaccine approach aims to block how a liver fluke parasite communicates with the human liver to prevent bile duct cancer in people in Southeast Asia.
-
Understanding why youth develop type 2 diabetes and how to prevent it
A nationwide study aims to unravel why some teens with obesity develop type 2 diabetes while others don’t, and to identify factors that could help prevent it.
-
Ultrasensitive antibody-detection method to screen HIV-bNAbs
A new, ultra-sensitive test will help identify which broadly neutralizing antibodies can best block HIV-1 in people, by quickly checking how well these antibodies interact with the virus in patient-derived samples.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.